Metabolic aspects in heart failure I

Samstag, 6. April | 10:00 - 11:30 Uhr | Posterbereich 24

Vorsitz/Chair: Susanne Rohrbach (Gießen), Rainer Schulz (Gießen)


Erhöhte myokardiale mitochondriale Effizienz bei Patienten mit nicht-ischämischer Herzinsuffizienz unter SGLT2-Inhibitor-Therapie
S. Kaufmann (Düsseldorf)
The mitochondria-targeted antioxidant mitoTEMPO has protective effects in mouse models of right ventricular pressure overload
E. Donhauser (Bad Oeynhausen)
Role of peroxisomes in compensatory metabolic adaptation in Barth syndrome cardiomyopathy
K. Elsie Vidah (Würzburg)
The NDPKB deficient mouse as a proper novel model for the study of cardiomyopathy associated with metabolic disorder
F. Shao (Mannheim)
Comparing immune cell-specific activation in HFpEF with and without obesity
J. M. Kneuer (Leipzig)
Molecular alterations of human diabetic heart disease revealed using single nucleus RNA sequencing
J. Gollmer (Graz)
Mutant DNAJC19 causes altered mitochondrial respiration and structural abnormalities
K. Walz (Würzburg)
Rat animal model for heart failure with preserved ejection fraction (HEpEF): A matter of diet
M. Kohlhaas (Würzburg)
Diese Seite teilen